Who is sponsoring NCT04829279?

NCT04829279 is sponsored by Yonsei University.

What drugs are being tested in NCT04829279?

Interventions in NCT04829279: CONNECT AI system group.

What condition does NCT04829279 study?

NCT04829279 studies Emergency Patient Transported by Ambulance.

Is NCT04829279 still recruiting?

NCT04829279 is currently completed. Last updated 7 July 2023.

Last reviewed 2023-07-07 · How we verify

NCT04829279

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Effectiveness for Connected Network for EMS Comprehensive Technical-support Using Artificial Intelligence (CONNECT-AI) System by Community Intervention

Completed NA Last updated 7 July 2023

What this trial tests

NA trial testing CONNECT AI system group in Emergency Patient Transported by Ambulance in 15,392 participants. Completed in 31 December 2021.

Timeline

1 May 2021

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Yonsei University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	none
Primary purpose	health services research
Enrollment	15,392
Start date	1 May 2021
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across South Korea

Drugs / interventions tested

CONNECT AI system group

Conditions studied

Emergency Patient Transported by Ambulance — all drugs for Emergency Patient Transported by Ambulance →

Sponsor

Yonsei University

Who can join

Adults 0 to 100, any sex, with Emergency Patient Transported by Ambulance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to verify the effectiveness of the connected network for EMS comprehensive technical-support using artificial intelligence (CONNECT-AI) system through demonstration in the local community. The study was designed as a prospective non-random cross-intervention study design in two preselected communities. The subjects of the study are patients transferred to the local emergency department(ED) through an ambulance of a fire department in the selected community. If the storage and transmission of information collected by an ambulance fails or the information of the transferred patient cannot be verified in the transferred ED, it is excluded from the study. In this study, the developed CONNECT-AI system was installed in all emergency vehicles and EDs in two regional cohorts, and the effectiveness was measured by operating an intersection for the same period. The primary outcome is the transfer time spent in the pre-hospital stage, and the secondary outcome is whether the optimal transfer hospital is selected.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Novel Artificial Intelligence-Enhanced Digital Network for Prehospital Emergency Support: Community Intervention Study.
Kim JH, Kim MJ, Kim HC, Kim HY, et al · · 2025 · cited 4× · PMID 39847421 · DOI 10.2196/58177

Verify or expand the search:

Other Yonsei University trials

Trials by the same sponsor.

NCT07547592 — Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma · Phase 2 · not yet recruiting
NCT07524101 — Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD · NA · not yet recruiting
NCT07506629 — Adductor Canal Block Methods in Bilateral Total Knee Arthroplasty · NA · not yet recruiting
NCT07515716 — Effects of High Flow Humidified Oxygen on Umbilical Artery Acid-base Balance in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07507188 — Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04829279 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yonsei University
Last refreshed: 7 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04829279.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing